Catalyst Wire Dossier Catalyst Wire Dossier

NEWBUTIN SR 300 mg Tab

trimebutine maleate
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NEWBUTIN SR 300 mg Tab, covering 2013-11-15 to 2013-11-15. Get the full timeline:

Most recent: Clinical Trial Update: Study of Trimebutine Maleate (NEWBUTIN SR 300 mg Tab)for Treatment of Post Operative Nausea and Vomiting [Phase 3]

See pricing